When nutrition interacts with osteoblast function: molecular mechanisms of polyphenols
Open Access
- 26 February 2009
- journal article
- review article
- Published by Cambridge University Press (CUP) in Nutrition Research Reviews
- Vol. 22 (1) , 68-81
Abstract
Recent research has provided insights into dietary components that may optimise bone health and stimulate bone formation. Fruit and vegetable intake, as well as grains and other plant-derived food, have been linked to decreased risk of major chronic diseases including osteoporosis. This effect has been partially attributed to the polyphenols found in these foods. Thus, it has been suggested that these compounds may provide desirable bone health benefits through an action on bone cell metabolism. The present review will focus on how some polyphenols can modulate osteoblast function and reports which cellular signalling pathways are potentially implicated. However, to date, despite numerous investigations, few studies have provided clear evidence that phenolic compounds can act on osteoblasts. Polyphenols cited in the present review seem to be able to modulate the expression of transcription factors such as runt-related transcription factor-2 (Runx2) and Osterix, NF-κB and activator protein-1 (AP-1). It appears that polyphenols may act on cellular signalling such as mitogen-activated protein kinase (MAPK), bone morphogenetic protein (BMP), oestrogen receptor and osteoprotegerin/receptor activator of NF-κB ligand (OPG/RANKL) and thus may affect osteoblast functions. However, it is also important to take in account the possible interaction of these compounds on osteoclast metabolism to better understand the positive correlation reported between the consumption of fruit and vegetables and bone mass.Keywords
This publication has 119 references indexed in Scilit:
- Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent mannerBiochemical and Biophysical Research Communications, 2008
- Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanonesBioorganic & Medicinal Chemistry, 2008
- Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cellsThe Journal of Nutritional Biochemistry, 2007
- Improved quantitative structure–activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systemsBioorganic & Medicinal Chemistry, 2007
- (−)‐epigallocatechin gallate enhances prostaglandin F2α‐induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblastsJournal of Cellular Biochemistry, 2006
- Flavonoids: antioxidants or signalling molecules?Free Radical Biology and Medicine, 2004
- Nutrigenomics: goals and strategiesNature Reviews Genetics, 2003
- Biology of bone and how it orchestrates the form and function of the skeletonEuropean Spine Journal, 2001
- ROLE OF CANONICAL GLUCOCORTICOID RESPONSIVE ELEMENTS IN MODULATING EXPRESSION OF GENES REGULATED BY THE ARYLHYDROCARBON RECEPTOR*Drug Metabolism Reviews, 1999
- Selective Expression of fos- and jun-Related Genes during Osteoblast Proliferation and DifferentiationExperimental Cell Research, 1995